Tox in Ten

In this episode Dr. Gillian Beauchamp sits down with Dr. Donna Papsun to discuss the nuance of forensic laboratory testing of Kratom products, especially with the development of synthetic Kratom alkaloids.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Patil Armenian to discuss how US federal law may hinder harm reduction efforts at mass gatherings/festivals and how toxicologists can get involved. 

In this episode Dr. Gillian Beauchamp sits down with Dr. Cait Bonney to discuss MDMA.  

ACMT Highlights Episode 70 - Festival Drugs   In this episode Dr. Gillian Beauchamp sits down with Dr. Benjamin Hatten to discuss drug use during festivals including self report of substances used versus what is found on surveillance testing.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Tim Erickson to discuss CBRNE and mass casualty training in Ukraine.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Robert "Cole" Pueringer to discuss 3 key features of fentanyl which lead to high opioid tolerance. This high opioid tolerance can lead to more severe withdrawal syndromes and difficulty with initiating buprenorphine or methadone.   Rapid inpatient methadone initiation may be more effective than outpatient initiation.

In this episode Dr. Gillian Beauchamp sits down with Dr. Benjamin Hatten to discuss the potential role of psychedelics in palliative care medicine. Specifically data that shows improved outcomes in individuals who experience psychological stress related to a terminal or life limiting illness that is refractory to more traditional treatments such as antidepressants

In this episode Dr. Gillian Beauchamp sits down with Dr. Patil Armenian to discuss strategies to promote physiologic as well as well as mental/emotional/psychiatric safety when psychedelics are used therapeutically and recreationally.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Laurie Halmo discuss the challenges of  making informed recommendations in regard to use of substances during pregnancy.

In this episode Dr. Gillian Beauchamp sits down with Dr. John Downs to discuss recommendations for at risk occupational PFAS testing (Aviation fire fighters, certain agricultural workers (exposure to " bio sludge" , workers exposed to organofluorines, ski waxers) and challenges of generalized testing.

In this episode Dr. Gillian Beauchamp sits down with Dr. Albert Garcia Romeu to discuss the history of psychedelic use, current treatment protocols and research on using psychedelics to support recovery from substance use disorders.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Michael Twiner and Dr. Brett Johnson to discuss harmful algal blooms (HABs) such as inhalation toxicity from Red Tide,   neurotoxic shellfish toxicity, diarrheal shellfish poisoning, and amnestic shellfish toxicity.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Michael Toce to discuss naloxone access laws, increased community availability of naloxone and who still doesn't have access to naloxone. They also discuss the difference between naloxone and nalmefene and the future of nalmefene.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Kevin Wenzel, PhD to discuss the importance of family involvement including identifying substance use disorder, seeking treatment and providing support during treatment.  

In this episode Dr. Gillian Beauchamp sits down with Jonathan Jarry MSc to discuss trends in health related pseudoscience and our role in fighting misinformation.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Andrew Stolbach to discuss the mechanishm of action,  toxicity and management of checkpoint inhibitors (immunotherapeutic agents used in the treatment of cancer).

In this episode Dr. Gillian Beauchamp sits down with Dr. Joshua Trebach to discuss the benefits and drawbacks of utilizing social media to increase awareness and promote medical toxicology.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Filza Hussain to discuss transplant organ allocation in patients who have organ failure secondary to a suicide attempt. 

In this episode Dr. Gillian Beauchamp sits down with Dr. Matthew Salzman discusses the complications associated with the use of illicit fentanyl containing xylazine from wounds to withdrawal.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Alan Wolfe to discuss the possible clinical effects of   POPs (Persistent Organic Pollutants) and PFAS (Per and polyfluoroalkyl substances).  

In this episode Dr. Gillian Beauchamp sits down with Dr. Travis Olives to discuss gap junctions and cardiac effects of bupropion toxicity.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Stephanie Weiss to discuss HERG channel blockade, QTc prolongation and cardiotoxicity.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Meghan Spyres to discuss the evolution of antivenom treatment of North American Pit Viper envenomation with specific discussion of the differences between Fab (CroFab) and F(ab)2 (ANAVIP) antivenom.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Christian Tomaszewski to discuss risk factors for delayed cardiomyopathy and mortality after carbon monoxide exposure.  

In this episode Dr. Gillian Beauchamp sits down with Dr. Alex Manini to discuss single nucleotide polymorphisms (SNPs) of the Mu receptor and how they may relate to overdose severity of opioid overdose.